Introduction {#ss1}
============

Bisphosphonate (BP)‐related osteonecrosis of the jaw (BRONJ) is defined as an unexpected appearance of exposed necrotic bone in the maxilla and mandible of patients having received BPs but have not undergone irradiation of the jaws ([Grötz *et al*, 2007](#b19){ref-type="ref"}). The clinical presentation of BRONJ is coupled with poor healing, spontaneous intraoral ulceration, and necrosis of the bone in the oral and maxillofacial regions ([Sehbai *et al*, 2007](#b57){ref-type="ref"}). BRONJ has been described in a variety of malignant and non‐malignant diseases including skeletal metastasis from solid tumors, multiple myeloma, and osteoporosis. It has been suggested that the risk of developing BRONJ is related to the duration and/or dosing frequency of BP treatment ([Ruggiero *et al*, 2004](#b51){ref-type="ref"}; [Durie *et al*, 2005](#b13){ref-type="ref"}; [Cremers and Farooki, 2011](#b9){ref-type="ref"}). Approximately 30% of patients with BRONJ are asymptomatic at clinical presentation, and the rest complain of severe local pain associated with soft‐tissue swelling, loosening of teeth, and drainage. Other symptoms may include numbness, heaviness, and dysesthesia of the affected jaw ([Vassiliou *et al*, 2010](#b62){ref-type="ref"}).

Initially, BRONJ was thought to be a very rare treatment‐related complication, but its incidence has been reported to be as high as 11% in patients receiving intravenous (IV) BP, and since 2006, the number of cases reported has grown significantly ([Woo *et al*, 2006](#b64){ref-type="ref"}; [Filleul *et al*, 2010](#b15){ref-type="ref"}).

The direct cause/effect relationship between BP treatment and BRONJ has yet to be elucidated although several possible mechanisms of BRONJ pathogenesis have been suggested including ischemia, reduced bone turnover, toxicity to bone, toxicity to soft tissue, microcracks, inflammation, and infection ([Lesclous *et al*, 2009](#b36){ref-type="ref"}; [Reid, 2009](#b48){ref-type="ref"}; [Hoefert *et al*, 2010](#b24){ref-type="ref"}; [Kumar *et al*, 2010](#b33){ref-type="ref"}). ONJ incidence correlation with BP potency suggests that inhibition of osteoclast function and differentiation might be a key factor in the pathophysiology of the disease. However, ONJ associated with patients receiving denosumab, a human RANKL monoclonal antibody ([Aghaloo *et al*, 2010](#b1){ref-type="ref"}), suggested another trigger for developing ONJ than BP therapy. The oral cavity is home to hundreds of microorganisms, and cases of bone necrosis secondary to BP therapy occur almost exclusively in the jaws where oral bacteria have access to bone (e.g., through saliva or odontogenic infection), especially after exposure of bone following a dental procedure such as an extraction. Compared with other parts of the body, bone can easily be colonized by the abundant flora of bacteria and yeast in the oral cavity that have the potential to cause biofilm‐mediated disease ([2008](#b55){ref-type="ref"}, [2009](#b56){ref-type="ref"}). Hoefert and Eufinger ([Hoefert and Eufinger, 2011](#b23){ref-type="ref"}) in their recent study indicated that long‐term preoperative antibiotic treatment can lead to a complete healing in 70--87% of cases in contrast to 35--53% with a short‐term regime. In addition, patients with cancer are routinely treated with immunosuppressive agents and these patients are susceptible to bacterial infections ([Kosmidis and Chandrasekar, 2012](#b30){ref-type="ref"}). Affected bone is an ideal incubator for periodontal and periapical bacteria, chronically stimulating inflammatory and immune responses ([Ricucci and Siqueira, 2008](#b49){ref-type="ref"}; [Rokadiya and Malden, 2008](#b50){ref-type="ref"}; [Heitz‐Mayfield and Lang, 2010](#b22){ref-type="ref"}). Although the disease can occur spontaneously, 90% of cases are coupled with surgical dental treatment, such as tooth extractions, mandibular exostoses, periodontal disease, and local trauma from ill‐fitting dentures.

Recently, we showed that the BRONJ tissue is heavily colonized by oral bacteria, and use of systemic antibiotics failed to restrict the bacterial colonization without effective healing of the lesion after the onset of BRONJ ([Ji *et al*, 2012](#b25){ref-type="ref"}). BP treatment may change the oral environment of the patient and BRONJ may be supported by increased bacterial adhesion to bone coated with BPs ([Kos and Luczak, 2009](#b29){ref-type="ref"}; [Kos, 2011](#b28){ref-type="ref"}). The bone exposition during the surgery or during tooth extraction acts as a trigger opening the door for bacterial invasion. As a result, it creates a more favorable condition for the growth of oral pathogens on the bone surface that may be a contributing factor to the development of BRONJ. To delineate the BRONJ pathogenesis, it is vital to identify the bacterial species/phylotypes that colonize jawbone associated with BRONJ. Moreover, it is not well understood whether the bacteria involved in bone infection associated with BRONJ is similar or different to other biofilm associated bone infections in the oral cavity ([Ruggiero *et al*, 2004](#b51){ref-type="ref"}; [2008](#b55){ref-type="ref"}, [2009](#b56){ref-type="ref"}) ([Ruggiero *et al*, 2009](#b52){ref-type="ref"}).

Here, we report the bacterial phylotypes that colonize the jawbone of BRONJ compared with non‐BP‐related bone infection in patients with cancer. Total bacterial profile was determined by 16S rRNA gene fragment analysis using denaturing gradient gel electrophoresis (DGGE) and sequencing. This is the first investigation using a culture‐independent approach studying bacterial colonization in bone samples of BRONJ compared with the bacterial profile of other bone infection(s) found in the oral cavity.

Methods {#ss2}
=======

Sample collection {#ss3}
-----------------

Twelve infected bone samples were collected from patients with cancer, including seven men and five women. The age range was 28--73, mean 58.25 (±11.46), six each from subjects with BRONJ (subjects with ONJ and history of BP therapy) and without BRONJ (no ONJ and no history of BP therapy (control). The term 'control' is broadly used throughout the article to refer to subjects not treated with BPs and without BRONJ but have cancer and jawbone infection that require surgical procedures as part of their standard of care treatment. Patients who were pregnant or lactating; who had a history of radiation therapy to the head and neck region; with BRONJ who had responded to conservative therapy and did not require surgical intervention; with osteonecrosis of the jaw that was associated with other conditions (e.g., Paget's disease of bone, fibro‐osseous lesion, metastatic cancer); who had any clinically significant condition (e.g., severe anemia or neutropenia, malnutrition, bleeding disorders, uncontrolled diabetes); and who were undergoing specific types of chemotherapy (e.g., bevacizumab) were eliminated from the study. The subjects were not on antibiotics at the time of sample collection. The samples were collected from patients with cancer who were referred to Dental Services, Memorial Sloan‐Kettering Cancer Center, for treatment for surgical procedures as part of their standard of care treatment. The samples were surgical debridement of bone and were obtained by sequestrectomy. Thus, no surgical procedure specific to this study was performed, and no additional material was collected from patients. The written informed consent was obtained from 12 patients with cancer selected for this study. This study was approved by the Institutional Review Board of Memorial Sloan‐Kettering Cancer Center and New York University School of Medicine Committee on Activities Involving Human Subjects. The demographic and clinicopathological data of the subjects were summarized in [Table 1](#t1){ref-type="table"}. All the samples were collected using sterile procedure and stored at −80°C.

###### 

 Demographic and clinical data of the subjects with BRONJ and control

  Sample no.   Gender   Age at first dental visit   History                                                    Type of IV BP (pamidronate, zoledronic acid, or both)   Site of infection
  ------------ -------- --------------------------- ---------------------------------------------------------- ------------------------------------------------------- -------------------------------------------
  01A          Male     50                          Large cell lymphoma of the liver                           None                                                    Carious, fractured maxillary teeth
  02A          Male     28                          NSGCT; testicular cancer                                   None                                                    Carious, fractured maxillary teeth
  03A          Female   58                          Amyloidosis in the setting of lymphoplasmacytic lymphoma   None                                                    Caries and periodontally infected tooth
  05A          Female   56                          Vocal cord SCC                                             None                                                    Extensive caries
  07A          Male     63                          SCC of the base of the tongue                              None                                                    Tooth mobility with furcation involvement
  08A          Male     66                          Multiple myeloma                                           None                                                    Large carious lesions
  04C          Male     65                          Renal cell carcinoma                                       Zoledronic acid                                         ONJ of RT and LT maxilla
  05C          Female   55                          Multiple myeloma                                           Both                                                    ONJ of RT and LT maxilla
  08C          Male     73                          Prostate cancer                                            Zoledronic acid                                         ONJ of LT mandible
  09C          Female   68                          Breast cancer                                              Both                                                    ONJ of LT mandible
  10C          Male     60                          Prostate cancer                                            Zoledronic acid                                         ONJ of RT mandible
  13C          Female   57                          Breast cancer                                              Zoledronic acid                                         ONJ of RT mandible

A, control; C, BRONJ; RT, right; LT, left; ONJ, osteonecrosis of the jaw.

Microscopy {#ss4}
----------

A subset of bone samples were preserved in 10% neutral buffered formalin, decalcified in 10% EDTA, pH 7.4, dehydrated, and embedded in paraffin. Sections were stained with hematoxylin and eosin and visualized under microscope.

DNA extraction and PCR amplification {#ss5}
------------------------------------

Bone samples were homogenized aseptically by sonication and treated with Proteinase K (2.5 μg ml^−1^) at 55°C overnight. Bacterial genomic DNA was extracted by the modified Epicentre MasterPure DNA purification protocol (Epicentre Biotechnologies, Madison, WI, USA) ([Ji *et al*, 2012](#b25){ref-type="ref"}). DNA concentration for all 12 samples was adjusted to 20 ng μl^−1^. The 16S rDNA was amplified with the universal primer pair 8F and 1492R to generate the 16S gene segments for cloning([Lane, 1991](#b34){ref-type="ref"}; [Paster *et al*, 2001](#b46){ref-type="ref"}). Each PCR mixture (50 μl) contained 5 μl of 10× PCR buffer, 1.5 μl of 50 mM MgCl~2~, 4 μl of 2.5 mM of each dNTP, 1 μl of 50 pmol of each primer, 1 μl of 5 U μl^−1^ Taq DNA polymerase, and 1 μl of the total genomic DNA. Standard PCR protocol includes an initial denaturation step of 5 min at 95°C, followed by 30 cycles that consisted of 1 min at 95°C, 1 min at 52°C, and 1 min at 72°C, plus an additional cycle of 5 min at 72°C for chain elongation. PCR products were resolved by electrophoresis in 1% agarose gel.

PCR‐based DGGE assay {#ss6}
--------------------

A set of universal bacterial 16S rDNA primers, forward primer bac1 (prbac1, 5′‐ACTACGTGCCAGCAGCC‐3′) and reverse primer bac2 (prbac2, 5′‐GGACTACCAGGGTATCTACTAATCC‐3′), were used to generate an approximately 300‐bp amplicon ([Rupf *et al*, 1999](#b53){ref-type="ref"}) ([Ji *et al*, 2012](#b25){ref-type="ref"}). A 40‐nucleotide GC‐clamp (CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGG) was added to the 5′ end of prbac1 ([Sheffield *et al*, 1989](#b58){ref-type="ref"}). Each PCR mixture (50 μl) contained 5 μl of 10× PCR buffer, 1.5 μl of 50 mM MgCl~2~, 4 μl of 2.5 mM of each dNTP, 1 μl of 50 pmol of each primer, 1 μl of 5 U μl^−1^ Taq DNA polymerase, and 1 μl of the total genomic DNA. An initial denaturation step of 3 min at 95°C was followed by 30 cycles that consisted of 30 s at 94°C, 40 s at 63°C, and 1 min at 72°C, plus an additional cycle of 7 min at 72°C for chain elongation. The amplicon sizes were confirmed by 1% agarose gel electrophoresis. For DGGE, a 40--60% linear DNA denaturing gradient (100%) denaturant is equivalent to 7 M of urea, and 40% deionized formamide was formed in 8% (w/v) polyacrylamide gels. Then, 30 μl of each PCR‐amplified product and species‐specific DGGE standard markers ([Li *et al*, 2005](#b38){ref-type="ref"}) were loaded in each lane and separated with the DCode System (Bio‐Rad, Hercules, CA, USA). Electrophoresis was performed at a constant 60 V at 58°C for 16 h in 1× Tris--acetate--EDTA (TAE) buffer (pH 8.5). After electrophoresis, gels were rinsed and stained for 15 min in water containing 0.5 μg ml^−1^ ethidium bromide, followed by 15‐min destaining in water. DGGE images were digitally captured and recorded with AlphaImager 3300 System (Alpha Innotech Corporation, San Leandro, CA, USA). All of the DGGE gel images were normalized first according to the known species‐specific DGGE reference markers and analyzed using Fingerprinting II Informatix (Bio‐Rad) and BioNumerics (Applied Maths, Austin, TX, USA) software([Li *et al*, 2007](#b40){ref-type="ref"}).

Cloning and sequencing {#ss7}
----------------------

According to the manufacturers' instructions, the PCR‐amplified 16S rDNA fragment (1500 bp) was ligated into the pCR 4‐TOPO vector and transformed into competent *E. coli* TOP10 cells using a TOPO TA Cloning Kit (Invitrogen, San Diego, CA, USA). A total of 1152 (12 samples, 96 clones per sample) clones were picked and submitted for sequencing (Beckman Coulter Genomics, Beverly, MA, USA). The trimmed 1066 sequences as received from the company were aligned by NAST alignment tool (<http://greengenes.lbl.gov/cgi-bin/nph-NAST_align.cgi>) ([DeSantis *et al*, 2006a](#b10){ref-type="ref"}) and checked for chimera by Chimera check with Bellerophon (version 3) using Greengenes (<http://greengenes.lbl.gov/cgi-bin/nph-bel3_interface.cgi>) ([2006a](#b10){ref-type="ref"}, [2006b](#b11){ref-type="ref"}). The phylotypes (the term 'phylotype' is broadly used for the bacteria at species level) were provisionally identified based on S_ab score to 16S rRNA gene sequences in the SEQ MATCH program of Ribosomal Database Project 16S rRNA database (Release 10 <http://rdp.cme.msu.edu/seqmatch/seqmatch_intro.jsp>) ([Maidak *et al*, 2001](#b41){ref-type="ref"}) The sequences with ≥450 bases and S_ab score ≥0.8 were selected for further analysis ([Pei *et al*, 2004](#b47){ref-type="ref"}; [Vickerman *et al*, 2007](#b63){ref-type="ref"}). On an average, most of the sequences had a length of 450--1000 bases.

Estimation of microbial biodiversity {#ss8}
------------------------------------

Sequence data related to species distribution were prepared in Microsoft Excel. Rarefaction and rank‐abundance curves, and diversity indices of Shannon index, Simpson index and evenness were determined by PAST (<http://folk.uio.no/ohammer/past/>) ([Hammer *et al*, 2001](#b20){ref-type="ref"}). Richness estimators Chao1 and abundance‐based coverage estimators (ACE) were conducted by ASLO (<http://www.aslo.org/lomethods/free/2004/0114a.html>) ([Kemp and Aller, 2004](#b27){ref-type="ref"}). The percentage of coverage was calculated by Good's method with the formula \[1‐(*n*/*N*)\] × 100, where *n* is the number of phylotypes in a sample represented by one clone (singletons) and *N* is the total number of sequences in that sample ([Good, 1953](#b18){ref-type="ref"}).

Results {#ss9}
=======

Microscopy {#ss10}
----------

Bisphosphonate‐related osteonecrosis of the jaw soft tissues showed inflammation that was verified by large bacterial masses along all bone surfaces in the biopsy. The sample was preserved in neutral buffered formalin, decalcified, and embedded in paraffin. Sections were stained with hematoxylin and eosin, resulting in the decalcified bone staining red/pink, and all bacteria and cellular debris stained dark blue or black. The layers of bacteria are aligned along all the bone surfaces and often are packed into the scalloped edges of the bone, giving the bone fragment a 'moth‐eaten' appearance ([Figure 1](#f1){ref-type="fig"}). No bone cells were found on the bone surface in these cases, and the osteocytes within the bone matrix were also dead and missing from their lacunae. This is a typical appearance of dead bone in ONJ samples found whenever a bacterial biofilm is present along the bone surface.

![ Histopathologic features of BRONJ. 'Moth‐eaten' BRONJ bone usually looks when massive amounts of bacteria are present. This is a standard decalcified bone sample with H&E staining. The bone is pink; all bacterial cells/colonies are dark blue](ODI-18-602-g001){#f1}

DGGE profile analysis {#ss11}
---------------------

Polymerase chain reaction/denaturing gradient gel electrophoresis assay differentiated PCR amplicons on the basis of sequence differences. The molecular profiles specified the presence of microorganisms within the bone samples representative of individual band of varying intensities ([Figure 2](#f2){ref-type="fig"}). The difference in bacterial diversity was clearly distinguished by cluster analysis with Ward's algorithm based on the Dice coefficient. A distinct cluster from the BRONJ group was observed, and five of six BRONJ profiles were grouped into one dendrogram branch (*P *=* *0.004). The DGGE profiles of the control (cluster I) were differentiated from those of the BRONJ (cluster II) in a separate cluster signifying altered microbial population ([Figure 3](#f3){ref-type="fig"}). The difference in the mean similarity values (87.5% ± 3.5%; *P *=* *0.001) between the two groups was statistically significant. The control and BRONJ subjects reflected approximately 75--90% and 65--90% homology, respectively, indicating that the bacterial species within the individual groups closely resemble each other.

![ DGGE profile of 300‐bp PCR amplicons from subjects with BRONJ and control. A: control; C: BRONJ; Marker I & II: DGGE reference markers of 16S rDNA gene fragment from stated typed bacterial species ([2005](#b38){ref-type="ref"}, [2006](#b39){ref-type="ref"}, [2007](#b40){ref-type="ref"})](ODI-18-602-g002){#f2}

![ The results of Ward's analysis of DGGE fingerprinting profile in which the Dice coefficient for measuring similarity algorithm in banding patterns was applied. The BRONJ and control groups displayed a statistically significant clustering of profiles, cluster I (control), and cluster II (BRONJ) (*P = *0.004). A: control; C: BRONJ](ODI-18-602-g003){#f3}

Phylogenetic analysis {#ss12}
---------------------

A total of 1066 sequences were generated, and 60 (5%) chimera sequences were detected and excluded from further analysis. With a cutoff of 450 bases, 93 (8%) sequences were eliminated and 913 (79%) were analyzed by RDP database to identify with a reference sequence at species/strain level.

A diversity of bacteria was found in both the control and BRONJ groups. We detected 7 distinct phyla, including *Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, Proteobacteria, Spirochaetes*, and one phylum named *TM7* with no currently known cultured representatives ([Figure 4](#f4){ref-type="fig"}). *Fusobacteria* was found only in the control group, while *TM7* was seen only in the BRONJ group. The predominant phylum in both the groups was *Firmicutes*, which was 61% in control group and much higher (76%) in BRONJ group. Twenty genera were identified within this phylum. Of cultured bacteria*, Lactobacillus gasseri* (11%) and *Streptococcus mutans* (6%) were predominant species in control group, while *Pseudoramibacter alactolyticus* (14%) and *Streptococcus mitis* (12%) predominated in the BRONJ group.

![ Relative distribution of bacteria at phylum level in bone samples of BRONJ and control](ODI-18-602-g004){#f4}

We identified 72 distinct species from 38 genera. *Lactobacillus* and *Streptococcus* were the biggest genera, both including 14% of the total cultured clones. *Pseudoramibacter alactolyticus (14%)*, *S. mitis (12%), Atopobium* sp. (9%), *Mogibacterium timidum* (9%), and *Bacteroidetes bacterium* oral taxon 272 (8%) were the predominant species in BRONJ group, while *Fusobacterium nucleatum* (9%), *L. gasseri* (11%), and *S. mutans* (6%) were the largest species in control group ([Figure 5](#f5){ref-type="fig"}). Thirteen bacterial species were exclusively present in BRONJ group, and 14 were present only in control, whereas nine were present in both the groups ([Table 2](#t2){ref-type="table"}). The most prevalent uncultured phylotypes found in BRONJ group were *Streptococcus* sp. oral taxon 064 (GU399337, 13%) and bacterium (EF511636, 7%; FJ470437, 6%), whereas *Clostridium* sp. (EF704878, 14%; EF695683, 9%), *Fusobacteria bacterium* (EF706831, 6%), and *Fusobacterium* sp. (EU932811, 6%) in control group (Supporting Information, Table S1).

![ Relative distribution of bacteria at genus level in bone samples of BRONJ and control](ODI-18-602-g005){#f5}

###### 

 Representative bacterial species identified in bone samples of BRONJ and control

  ------------------------------------------------------------------------------
  Only detected in control
  * Aquitalea magnusonii* (T); DQ018117
  * bacterium* LMa1; AY766420
  * Eubacterium brachy*; GU415605; GU415654
  * Fusobacterium nucleatum* subsp. *nucleatum*; ATCC 25586(T); AJ133496
  * Fusobacterium nucleatum*; GU407941; GU407729; GU424732; GU424733; GU407836
  * Lactobacillus gasseri*; ATCC 33323, AF519171; AB517146; AF243156; AY190611
  * Lactobacillus paracasei* subsp. paracasei; AB126872
  * Lactobacillus rhamnosus*; ATCC 7469a, AF429476; AY675254; GU812308
  * Olsenella* genomosp. C1; AY278623
  * Porphyromonas gingivalis*; GU418042; AB035456
  * Propionibacterium acnes*; AB108480; AJ404530
  * Streptococcus constellatus*
  * Streptococcus sanguinis*; GU426565; GU426750
  * Veillonella parvula*; GU405744; GU405377
  Only detected in BRONJ group
  * Atopobium* sp. oral clone C019/oral taxon 199; AF287760; GU407672
  * Bacteroidetes bacterium* oral taxon 272; GU408960; GU409022
  * Dialister invisus* (T); AY162469
  * Finegoldia magna*; ATCC 29328; AB109769
  * Moryella indoligenes*; AF527773
  * Oribacterium* sp. oral taxon 372; GU410908; GU410944
  * Porphyromonas endodontalis*; GU409135
  * Prevotella denticola* (T); ATCC 35308; AY323524
  * Prevotella nigrescens*; GU424692
  * Prevotella tannerae*; AF183406; GU413117
  * Selenomonas infelix*; GU420018
  * Shuttleworthia satelles*; GU400731; GU400716; GU400724
  * Streptococcus mitis*; U02918; GU422122; AY518677; GU411571
  Detected in both groups
  * Atopobium* sp. DMCT15023; EU186380
  * Lactobacillus fermentum*; FJ966277
  * Mogibacterium timidum*; ATCC 33093, Z36296; GU398214
  * Olsenella profusa*; AF292374; GU428144; GU428150
  * Parvimonas micra*; GU401060; GU401106; GU401272; GU401120; GU401157
  * Pseudoramibacter alactolyticus*; GU414641; GU414708; GU414693
  * Streptococcus parasanguinis*
  * Streptococcus mutans*; AJ243965
  * Veillonella dispar*; GU404476
  ------------------------------------------------------------------------------

BRONJ, bisphosphonate‐related osteonecrosis of the jaw.

Species richness and diversity {#ss13}
------------------------------

Rarefaction curves were plotted by the number of observed phylotypes as a function of the numbers of clones at 95% confidence level from control group and BRONJ group by using the individual‐based method ([Krebs, 1989](#b31){ref-type="ref"}). It quickly reached an asymptotic maximum for both groups ([Figure 6](#f6){ref-type="fig"}). The rank‐abundance curves exhibited a similar pattern for control and BRONJ group bacterial communities ([Figure 7](#f7){ref-type="fig"}). A few species were abundant; the long right‐hand tail on the rank‐abundance curve was a result of rare species.

![ Individual rarefaction curves of BRONJ and control libraries](ODI-18-602-g006){#f6}

![ Rank‐abundance curves of bacterial phylotypes in BRONJ and control samples](ODI-18-602-g007){#f7}

For Shannon, Simpson, and evenness indices, the higher values in the BRONJ group suggested that this group had higher diversity and evenness of species distribution compared to control group ([Table 3](#t3){ref-type="table"}). Lower values of Good's coverage, predicted S~ACE~, and predicted S~Chao1~ for BRONJ group indicated that more new phylotypes would be expected in additional sample set in this group than control group. The value of observed phylotypes/predicted S~ACE~ and the value of observed phylotypes/predicted S~Chao1~ for control and BRONJ groups were very similar.

###### 

 Estimation of species richness and diversity indices of bacterial phylotypes present in BRONJ and control libraries

                                           Control   BRONJ
  ---------------------------------------- --------- --------
  Taxa_S                                   82        60
  Individuals                              266       161
  Shannon_H                                3.83      3.71
  Simpson_1‐D                              0.96      0.97
  Evenness_e\^H/S                          0.56      0.68
  Good's coverage (%)                      85        81
  Predicted value of S~ACE~                127.01    118.77
  Predicted value of S~Chao1~              127.02    110.87
  Observed phylotypes/predicted S~ACE~     0.64      0.59
  Observed phylotypes/predicted S~Chao1~   0.65      0.71

ACE, abundance‐based coverage estimators; BRONJ, bisphosphonate‐related osteonecrosis of the jaw.

Discussion {#ss14}
==========

To our knowledge, there are no published data on the characterization of the bacterial profile found in jawbone from patients with BRONJ. In this study, we used culture‐independent molecular phylogenetic methods to identify the bacterial phylotypes from subjects with BRONJ and control (without BRONJ and no history of BP). Bacterial 16S rDNA was PCR‐amplified with universal primers, followed by DGGE, cloning, and sequencing to allow an unrestricted and quantitative investigation of the bacterial population present on jawbone associated with BRONJ.

Microscopic studies supported the assumption that the BRONJ bones are deeply colonized by bacteria. The layers of bacteria are aligned along all the bone surfaces and often packed into the scalloped edges of the bone, giving the bone fragment a 'moth‐eaten' appearance. This is a typical presentation of dead bone in BRONJ samples found infected with oral bacteria ([2008](#b55){ref-type="ref"}, [2009](#b56){ref-type="ref"}). Similarly, [Sedghizadeh *et al* (2008)](#b55){ref-type="ref"} demonstrated by SEM that the bone specimens from affected sites in all patients had large areas occluded with biofilms comprising mainly bacteria, and occasionally yeast, embedded in extracellular polymeric substance, while control bone tissue was unremarkable, indicating that the bone specimens BRONJ are colonized by specific oral bacteria.

We also used a molecular fingerprinting technique DGGE ([2005](#b38){ref-type="ref"}, [2006](#b39){ref-type="ref"}) to evaluate the predominant bacterial species present in bone samples. DGGE analysis results demonstrate that each group has its unique pattern of 16S rDNA species and displayed statistically significant clustering of profiles ([2](#f2){ref-type="fig"}, [3](#f3){ref-type="fig"}). The banding pattern indicated that some bacterial species/phylotypes present in one group were either reduced in numbers or absent in other group ([Figure 2](#f2){ref-type="fig"}). The results of our study also demonstrated that the DGGE profiles of each group type formed significant group‐specific clusters. Moreover, the overall BRONJ and control profiles were more similar within each group than between the groups, which suggest the presence of common phylotypes associated with BRONJ or other dental infection. These results demonstrated that BRONJ group can be predicted with reasonable accuracy based on DGGE banding patterns. Even though the molecular fingerprinting profile does not provide immediate discrimination among bacterial species, it does enable the simultaneous analysis of multiple samples and thus facilitates the direct comparison of bacterial communities from different samples of interest.

The phylogenetic analysis by cloning and sequencing matches the DGGE profile. A bacteria‐rich microbiota was present in the control and BRONJ groups. Phyla of *Actinobacteria, Bacteroidetes, Firmicutes,* and *Proteobacteria*, which are associated with other bacterial infections in oral cavity, were present in both groups ([Paster *et al*, 2001](#b46){ref-type="ref"}; [Kumar *et al*, 2005](#b32){ref-type="ref"}; [Vickerman *et al*, 2007](#b63){ref-type="ref"}; [2008](#b55){ref-type="ref"}, [2009](#b56){ref-type="ref"}).

The phylum *Fusobacteria* (15%) was detected only in the control group, whereas the phylum *TM7* was only found in BRONJ group (2%). Species within this phylum have been commonly identified in both healthy subjects and those with periodontitis ([Paster *et al*, 2001](#b46){ref-type="ref"}). It was reported that *TM7* was strongly associated with subgingival plaques ([Paster *et al*, 2001](#b46){ref-type="ref"}; [Brinig *et al*, 2003](#b6){ref-type="ref"}; [Ouverney *et al*, 2003](#b45){ref-type="ref"}; [Ledder *et al*, 2007](#b35){ref-type="ref"}), and there are no cultured representatives of this phylum. The top three genera ranked among the BRONJ group were *Streptococcus* (29%), *Eubacterium* (9%), and *Pseudoramibacter* (8%), while in the control group were *Parvimonas* (17%), *Streptococcus* (15%), and *Fusobacterium* (15%) ([Figure 5](#f5){ref-type="fig"}). *Actinomyces* are usually considered as opportunistic pathogens, and many species in this genus have been reported to be associated with periodontal disease, osteomyelitis, as well as BRONJ ([Fine *et al*, 1999](#b16){ref-type="ref"}; [Slots and Ting, 1999](#b59){ref-type="ref"}; [Tonetti and Mombelli, 1999](#b61){ref-type="ref"}; [Hansen *et al*, 2006](#b21){ref-type="ref"}; [Estilo *et al*, 2008](#b14){ref-type="ref"}; [Naik and Russo, 2009](#b42){ref-type="ref"}). However, in our BRONJ samples, we did not observe high number of *Actinomyces.* Naik and Russo ([Naik and Russo, 2009](#b42){ref-type="ref"}) reported the presence of the actinomyces‐like organisms from bone associated with BRONJ and in an another study using histomorphometric analysis of oral mucosa and jawbones have shown that *Actinomyces* is associated with BRONJ ([Kaplan *et al*, 2009](#b26){ref-type="ref"}); however, most of these assumptions were based only on microscopic observations. We used molecular 16S rRNA gene and *Actinomyces* primers in combination of universal primers ([Olson *et al*, 2007](#b43){ref-type="ref"}; [Sakamoto *et al*, 2008](#b54){ref-type="ref"}) but did not observe high abundance of *Actinomyces* as indicated by DGGE gel ([Figure 2](#f2){ref-type="fig"}, lower bottom bands) and sequencing. More significantly, we identified 13 strains that were only present in BRONJ ([Table 2](#t2){ref-type="table"}). The presence of these opportunistic organisms such as *Finegoldia magna*, gram‐positive bacteria responsible for prosthetic infections, septic arthritis, and other bone and joint infections ([Levy *et al*, 2009](#b37){ref-type="ref"}); *Moryella indoligenes*, gram‐positive bacteria responsible for abscess ([Carlier *et al*, 2007](#b8){ref-type="ref"}); *Oribacterium*, gram‐negative after staining but structurally gram‐positive responsible for maxillary sinusitis and its major metabolic end products are acetic, butyric, and lactic acids ([Carlier *et al*, 2004](#b7){ref-type="ref"}); *Selenomonas infelix*, gram‐negative anaerobic bacilli normally found in human buccal flora and can cause bacteremia and lung abscess in a patient with cancer ([Bisiaux‐Salauze *et al*, 1990](#b5){ref-type="ref"}); and species of *Porphyromonas* and *Prevotella,* responsible for endodontic infections ([Gomes *et al*, 2005](#b17){ref-type="ref"}), indicated that BRONJ lesions/bone are colonized by different bacteria than those that are present in other biofilm‐associated jawbone infections.

An understanding of the infectious disease process requires knowledge of the entire bacterial community, and how these bacteria are involved in disease progression. 16S rDNA libraries can be used to determine the abundance and richness of any bacterial species present in sample. We used S~Chao~1 and S~ACE~ estimator to determine the real phylotype abundance distributions in our samples ([Kemp and Aller, 2004](#b27){ref-type="ref"}). The ratio of observed phylotypes to predicted S~Chao1~ was 0.65 for control group and 0.71 for BRONJ group, and the ratio of observed phylotypes to predicted S~ACE~ was 0.64 for control group and 0.59 for BRONJ group. These data suggested that with larger sample size, a more precise estimate of phylotype richness would be possible. However, the Shannon index, which indicates rarity and commonness of species, indicated that control and BRONJ had high species evenness and richness. The diversity of bacteria in the control group (H′ = 3.83 ± 0.1) was greater than that in BRONJ group (H′ = 3.71 ± 0.1). Simpson index, which represents the number of species present, as well as the abundance of each species, indicated that both the groups had ≥0.96, which meant that the probability of two clones from one of the groups that belonged to the same species was ≤4%. The Good's coverage and evenness index indicated that our sequencing results covered 85% of species present in BRONJ samples, and the individuals (species) were distributed more evenly in BRONJ group than the controls. These data proved that the sample sets had high bacterial diversity and richness, and with limited sample size, we can determine the bacterial profile associated with each group.

There are many hypotheses for BRONJ pathogenesis ([Allen and Burr, 2009](#b2){ref-type="ref"}) the manifestation of necrotic bone resulting from BP‐induced remodeling suppression that allow accumulation of non‐viable osteocytes, direct cytotoxic effect of BPs on osteocytes, BPs antiangiogenic effects, and role of oral bacteria. Our observations indicated that the BRONJ bone was colonized by bacteria, and the bacterial phylotypes were different from other bone infections in the oral cavity not associated with BP therapy. *Staphylococcus aureus* is the predominant cause of osteomyelitis, and the composition of local flora may allow other pathogens access to the bone; however, in our study, we did not detect any *S. aureus* which indicated that there may be other oral bacteria which can trigger bone infection in BRONJ. Bacterial profile of our control group was similar to other jawbone infection like caries and periodontal disease ([Dewhirst *et al*, 2010](#b12){ref-type="ref"}). The BRONJ group had totally different bacterial phylotypes that are not associated with other jawbone infections ([Table 2](#t2){ref-type="table"}), but are known to cause other opportunistic infections. The plausible basis for BRONJ development is also the increased bacterial adhesion to the BP‐covered bone ([Allen and Burr, 2009](#b2){ref-type="ref"}; [Kos and Luczak, 2009](#b29){ref-type="ref"}). Kos and Luczak ([Kos and Luczak, 2009](#b29){ref-type="ref"}; [Kos, 2011](#b28){ref-type="ref"}) proposed that BRONJ may result from increased bacterial adhesion to bone coated with BPs. In their mouse models, zoledronic acid promoted the adherence and proliferation of *S. mutans* to hydroxyapatite, suggesting that zoledronic acid may increase bacterial infection. They further suggested that this could be mediated by proteins termed 'microbial surface components which recognize adhesive matrix molecules' (MSCRAMM) and that the binding of gram‐positive strains was attributed to the amino‐terminal domain of MSCRAMM structure that may play a significant role in the pathogenesis of infection ([Kos and Luczak, 2009](#b29){ref-type="ref"}; [Kos, 2011](#b28){ref-type="ref"}). Similarly, in our studies, we observed that BRONJ bone was colonized by bacteria which were different from bone infections that were not associated with BP, indicating that BP may play a significant role in bacterial colonization of jawbone. The cationic amino group of nitrogen‐containing BPs may attract bacteria by direct electrostatic interaction, through a direct surface protein interaction or by providing an amino acid mimic on the surface of the bony hydroxyapatite that interacts with MSCRAMM component and mediates increased bacterial adhesion ([Kos and Luczak, 2009](#b29){ref-type="ref"}; [Kos, 2011](#b28){ref-type="ref"}). We did not observe high number of *S. mutans*, but we did observe high number of organisms that belong to genus *Streptococcus* and other organisms such as *Oribacterium*. It is also hypothesized that the bone is healthy until it is injured and infected with specific oral bacteria, and reduced resorptive ability caused by BP hinders the formation of new bone or there may be vascular damage caused by BP ([Street *et al*, 2002](#b60){ref-type="ref"}; [Aspenberg, 2006](#b3){ref-type="ref"}; [Bi *et al*, 2010](#b4){ref-type="ref"}). Infection could contribute to BRONJ by enhancing osteoclast‐independent bone resorption. BRONJ tissue consistently shows a prevalence of scalloped bone surfaces, a seemingly paradoxical property, given the effect of BPs on bone resorption. Bacteria and associated fibroblast‐like cells have the capacity to directly resorb bone, independent of osteoclasts, by liberating various acids and proteases ([Allen and Burr, 2009](#b2){ref-type="ref"}).

The acidic environment created by high abundance of aciduric bacteria especially *Streptococcus* and other saccharolytic bacteria may play a significant role in bone necrosis. In humans, acidic environments are common in infections and wound healing after surgical procedures. pH values less than 6.2 are common during infections, which may further enhance the growth of aciduric bacteria. In either case, there is an infectious environment that plays a significant role in the pathogenesis of BRONJ, and other factors such as dental infections, invasive procedures, and nitrogen‐containing amino‐BPs can act as initiators of BRONJ ([Otto *et al*, 2010](#b44){ref-type="ref"}). At this stage, it is not known whether bacteria colonize and promote the lesion, or whether they colonize after the lesion has developed. In either case, 'identification of unique bacterial phylotypes' will be highly significant for understanding and monitoring the pathophysiology and treatment of BRONJ.

Our results, using a limited sample size, demonstrated the presence of diverse and unique bacterial communities in BRONJ, which raises an intriguing question about the role of oral bacterial in BRONJ pathogenesis. The existence of certain abundant known and as‐yet‐uncultured species in the BRONJ group may reflect its association with BRONJ. Further studies using large sample size are warranted to determine the significance of these specific oral bacterial in BRONJ pathogenesis.
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